BIO-key International, Inc.
BKYI
$0.715
-$0.0003-0.04%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.39M | 6.06M | 6.85M | 6.85M | 7.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.39M | 6.06M | 6.85M | 6.85M | 7.69M |
| Cost of Revenue | 5.45M | 6.46M | 7.80M | 8.82M | 5.39M |
| Gross Profit | 944.80K | -394.40K | -950.60K | -1.97M | 2.30M |
| SG&A Expenses | 7.77M | 7.94M | 8.14M | 8.29M | 8.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.66M | 16.72M | 18.23M | 19.48M | 16.90M |
| Operating Income | -9.27M | -10.65M | -11.38M | -12.63M | -9.21M |
| Income Before Tax | -9.37M | -10.46M | -11.28M | -12.46M | -12.82M |
| Income Tax Expenses | -276.80K | -277.00K | -134.00K | -134.00K | 122.40K |
| Earnings from Continuing Operations | -9.09 | -10.19 | -11.14 | -12.32 | -12.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.09M | -10.19M | -11.14M | -12.32M | -12.94M |
| EBIT | -9.27M | -10.65M | -11.38M | -12.63M | -9.21M |
| EBITDA | -8.79M | -10.21M | -10.94M | -12.20M | -8.86M |
| EPS Basic | -10.12 | -12.95 | -16.66 | -19.85 | -26.29 |
| Normalized Basic EPS | -6.69 | -8.64 | -10.75 | -12.93 | -13.14 |
| EPS Diluted | -10.12 | -12.95 | -16.66 | -19.85 | -26.29 |
| Normalized Diluted EPS | -6.69 | -8.64 | -10.75 | -12.93 | -13.14 |
| Average Basic Shares Outstanding | 5.90M | 4.58M | 3.48M | 2.34M | 2.07M |
| Average Diluted Shares Outstanding | 5.90M | 4.58M | 3.48M | 2.34M | 2.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |